Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 330 Breast Neoplasms 185 Lung Neoplasms 177 Ovarian Neoplasms 156 Triple Negative Breast Neoplasms 88 Fallopian Tube Neoplasms 75 Squamous Cell Carcinoma of Head and Neck 74 Small Cell Lung Carcinoma 67 Esophageal Neoplasms 55 Neoplasms 49 Head and Neck Neoplasms 47 Carcinoma, Ovarian Epithelial 44 Uterine Cervical Neoplasms 36 Esophageal Squamous Cell Carcinoma 36 Endometrial Neoplasms 35 Prostatic Neoplasms 33 Neoplasm Metastasis 32 Lymphoma, Large B-Cell, Diffuse 32 Recurrence 31 Adenocarcinoma of Lung 31 Lymphoma 30 Brain Neoplasms 29 Neuroblastoma 24 Central Nervous System Neoplasms 24 Retinoblastoma 23 Lymphoma, Non-Hodgkin 23 Carcinoma, Squamous Cell 23 Hodgkin Disease 20 Testicular Neoplasms 19 Urinary Bladder Neoplasms 16

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasm Female × Carboplatin × Clear all

NCT06234137 2024-01-31

neoPICD

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡